PAYSNasdaqServices-Business Services, NECFiscal year ends December 31
Paysign, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$15.34+0.54 (+3.65%)
Close on Oct 19, 2026
- Market cap
- $950.70M
- P/E (TTM)
- 59.0
- Dividend yield
- –
Paysign, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharma Industry [Member] | $14.65M | $15.68M | $9.60M | $7.92M | $7.75M | $8.62M | $4.31M | $3.27M | $2.67M | $2.39M | – | – | 51.9% | +88.9% |
| Plasma Industry [Member] | $13.04M | $11.75M | $12.60M | $12.86M | $10.74M | $9.41M | $10.80M | $11.44M | $11.27M | $10.37M | $11.52M | $11.06M | 46.2% | +21.4% |
| Other Revenue [Member] | $562.40K | $610.36K | $558.37K | $815.40K | $580.52K | $569.62K | $493.79K | $542.01K | $383.44K | $433.40K | $468.11K | $312.34K | 2.0% | -3.1% |
| Breakage Revenue [Member] | $75.63K | $112.05K | – | – | $54.93K | $101.19K | – | – | – | – | – | – | 0.3% | +37.7% |
| Settlement Revenue [Member] | $0 | $0 | – | – | $0 | – | – | – | – | – | – | – | 0.0% | – |
| Pharmaceutical Industry [Member] | – | – | – | – | – | – | – | $3.27M | $2.67M | $2.39M | $1.71M | $1.03M | – | – |
By region
From the segment and revenue-disaggregation notes of Paysign's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.